Value-Based Care

A new report reveals Europe's medically-focused cannabis market is finally waking, creating a new global blueprint but also intense competition and price wars.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

Millions of women struggle with sleep, and hormones are the silent saboteur. Discover the science behind hormonal sleep disruption and expert-backed solutions.

A new report shows hospitals in a federal drug discount program provide less charity care than others, fueling calls for urgent federal reforms.

With strong clinical data for its Dayspring system, Koya Medical is pitching to investors to fund the next phase of growth for its patient-centered tech.

A landmark Novo Nordisk study finds 2 in 5 heart patients have hidden inflammation, a major risk for heart attack and stroke despite standard treatments.

French biotech TreeFrog Therapeutics isn't just replacing cells; it's implanting pre-wired networks. Their novel 3D microtissue shows faster, more extensive brain repair.

Studies reveal an AI platform slashes cancer patient hospitalizations by up to 51% and saves millions, heralding a new era of remote oncology care.

The Vaya Partners merger creates a 47-county giant serving 222,000 people, promising stability but facing huge integration and regulatory challenges.

Motivity's deal to acquire Calmanac creates an all-in-one ABA platform, merging top-tier clinical and operational tech to challenge market leaders.

South Jersey's Virtua Health soars in national rankings, proving that compassion, trust, and human connection are the new benchmarks in modern healthcare.

A landmark survey shows medical cannabis helps 97% of mental health patients, but experts urge caution, highlighting a divide between patient experience and clinical proof.

A revolutionary single-dose, over-the-counter cold sore tablet launches in Europe, promising new convenience for millions and shaking up the self-care market.

Caliway Biopharma advances its fat-loss drug, promising objective, MRI-verified results in a market hungry for safer, more reliable aesthetic options.

A North Carolina firm is tackling the two biggest threats to retirement security: soaring healthcare costs and taxes. Here's how their tech-driven plan works.

At SLAS 2026, MGI Tech unveiled intelligent platforms for proteomics and clinical automation, signaling a major push to accelerate scientific discovery.

Teva's new once-monthly olanzapine injection could revolutionize schizophrenia care in Europe, offering hope for better treatment adherence and patient outcomes.

Pioneers of IVF technology are launching a clinical skincare program, aiming to merge cellular science with holistic patient support in fertility clinics.

A landmark symposium unites leaders to combat staggering maternal mortality rates with a new strategic plan, focusing on collaboration and lived experience.

Central Ohio cancer patients gain unprecedented access to advanced therapies and clinical trials as Zangmeister Cancer Center joins OSU's James Cancer Network.